Pfizer. Ulta Beauty Fall Premarket; Docusign Rises

Pfizer. Ulta Beauty Fall Premarket; Docusign Rises

© Reuters.  © Reuters.

By Peter Nurse

Investing.com — Stocks in focus in premarket trade on Friday, December 4th. Please refresh for updates.

  • Pfizer (NYSE:PFE) stock fell 0.3% after the pharma giant halved the number of Covid-19 vaccine doses it plans to ship out this year, cooling hopes of a rapid rollout.

  • AMC Entertainment (NYSE:AMC) stock rose 0.6%, rebounding after Thursday’s 16% slump, Warner Bros., the world's second-largest movie studio, announced it would stream all of its 2021 movies at the same time they hit theaters.

  • DocuSign (NASDAQ:DOCU) stock rose 4.4% after the electronic-documents company posted better-than-expected results for its fiscal third quarter, continuing to gain customers, who turned to electronic signatures to close contracts in this pandemic.

  • Ulta Beauty (NASDAQ:ULTA) stock fell 4% after the chain of beauty stores disappointed with its net sales in its third-quarter results, with a number of its stores still closed in the pandemic. It was still able to lift guidance for fourth-quarter comparable-store sales.

  • Cloudera (NYSE:CLDR) stock soared 12% after the software company beat expectations with its third-quarter results. It also announced the repurchase of an additional $500 million of stock.

  • Pagerduty (NYSE:PD) stock soared 16% after the software company impressed with its third-quarter results and lifted its outlook for the year ending in January.

  • Facebook (NASDAQ:FB) stock rose 0.1% despite the U.S. Department of Justice launching a lawsuit against the social media giant alleging discrimination against American workers by giving hiring preferences to immigrants.

  • Boeing (NYSE:BA) stock rose 1.4%, continuing Thursday’s gains after Ryanair (NASDAQ:RYAAY) agreed to firm up a provisional order for 75 of the aircraft maker’s 737 MAX jets, a sign the company’s woes may be coming to an end.

Original Article

Leave a comment

Send a Comment

Your email address will not be published. Required fields are marked *